サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1576946

アンギオスイート - 市場考察、競合情勢、市場予測（～2030年）

Angio Suites - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.54円
アンギオスイート - 市場考察、競合情勢、市場予測（～2030年）
出版日: 2024年10月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアンギオスイートの市場規模は、2023年に21億8,000万米ドルであり、2030年までに30億5,000万米ドルに達すると予測され、2024年～2030年の予測期間にCAGRで5.75%の成長が見込まれます。市場は主に、心房細動、末梢動脈疾患（PAD）、冠動脈疾患（CAD）などの心血管疾患のような慢性疾患の患者の増加、主要企業による革新的な製品開発活動、老年人口の増加により大幅な市場成長を示しており、これらが2024年～2030年の予測期間にアンギオスイート市場全体の成長を加速させると予測されます。

アンギオスイートの市場力学

World Heart Report（2023年）が提供したデータによると、2021年に5億人以上の人々が世界的に心血管疾患を抱えて生活しています。さらに、American Heart Association（2023年）が提供した近年のデータによると、2030年までに世界で1,200万人以上が心房細動に罹患すると推定されています。

British Heart Foundation、Global Heart & Circulatory Diseases Factsheet（2024年）によると、世界中で約2億人がCADとともに生活しています。

American Heart Association（2023年）のデータによると、世界平均で約2億人がPADとともに生活しています。また、Global Burden of Disease（2019年）によると、2019年の全世界の40歳～70歳のPAD有病者数は5,640万人でした。

アンギオスイートは、CAD、PAD、心房細動などの心血管疾患の診断と治療に不可欠です。さらに、アンギオスイートは、正常な心拍リズムを回復する心房細動アブレーションのようなカテーテルベースの手技に使用することができます。

アンギオスイート市場の成長をもたらすもう1つの大きな要因は、製品の設計に向けた、アンギオスイート市場における安全性と精度を高めるための絶え間ない技術開発です。例えば2021年10月、インドのセクンダラバードにあるYashoda Hospitalsは、脳卒中や心臓発作などの神経学的な急病の場合に迅速かつ先進の治療を提供するために使用されるDTAS（Direct to Angio Suite）技術を搭載した「Bi-Plane Neuro Angio Procedure Suite」を発売しました。

世界中の規制機関による製品開発活動の活発化も、アンギオスイートの市場成長をもたらす見込みです。例えば2022年5月、Philipsは新しいMR 7700 3.0T MRシステムのFDA 510（k）認可を発表しました。

したがって、上記のすべての要因が総合的にアンギオスイート市場全体の成長を促進します。

しかし、感染症、血腫、血管損傷などの副作用、熟練した労働力や医療インフラの不足などは、アンギオスイート市場の成長の課題となる可能性があります。

アンギオスイート市場のセグメント分析

アンギオスイート市場の用途セグメントでは、ステント留置術カテゴリが2023年に大きな収益シェアを占めると予測されています。これは、脳卒中の急患に必要とされるステント留置術が世界中で増加していることや、脳卒中の有病率が世界的に増加し障害や死亡などの深刻な結果につながっていることによるものと考えられ、アンギオスイート市場のこのセグメントはかなりの収益を生み出すと予測されています。

さらに、ウェアラブルアンギオスイートの開発で行われている技術の進歩や製品革新は、アンギオスイート市場の成長を促進する可能性が高いです。例えば2022年6月、Siemens Healthineersは、ステント留置術や脳卒中の診断と治療などのさまざまな用途の血管造影システムArtis Iconoを発売しました。このシステムは、シームレスな統合とサードパーティインターフェースを備えた2D・3Dイメージング用の新しいシステム機構とイメージチェーンによって実現されています。

当レポートでは、世界のアンギオスイート市場について調査分析し、各地域の市場規模と予測、過去3年の製品/技術開発、市場の主要企業、将来の機会などの情報を提供しています。

目次

第1章 アンギオスイート市場レポートのイントロダクション

第2章 アンギオスイート市場のエグゼクティブサマリー

  • 市場の概要

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 アンギオスイート市場の主な要因の分析

  • アンギオスイート市場の促進要因
  • アンギオスイート市場の抑制要因と課題
  • アンギオスイート市場の機会

第6章 アンギオスイート市場のポーターのファイブフォース分析

第7章 アンギオスイート市場の評価

  • タイプ別
    • シングルプレーン
    • バイプレーン
  • 用途別
    • 血管造影
    • 血管形成術
    • ステント留置術
    • バイパス手術
    • その他
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 アンギオスイート市場の企業と製品のプロファイル

  • Siemens Healthineers
  • Koninklijke Philips N.V
  • Lam Vascular and Associates
  • Hitachi, Ltd.
  • ESAOTE SPA
  • IMRIS
  • Onex Corporation
  • Canon Inc.
  • 3D Systems, Inc.
  • GE HealthCare
  • Shimadzu Corporation
  • GIMIAS
  • FUJIFILM Holdings Corporation
  • Hologic, Inc.
  • Planmeca
  • Mindray Medical International Limited
  • ZEISS International
  • Guerbet
  • Surgical Science
  • B.Braun Melsungen AG

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Angio Suites Market in Global (2021-2030)
  • Table 3: Angio Suites Market in Global by Type (2021-2030)
  • Table 4: Angio Suites Market in Global by Application (2021-2030)
  • Table 5: Angio Suites Market in Global by Geography (2021-2030)
  • Table 6: Angio Suites Market in North America (2021-2030)
  • Table 7: Angio Suites Market in the United States (2021-2030)
  • Table 8: Angio Suites Market in Canada (2021-2030)
  • Table 9: Angio Suites Market in Mexico (2021-2030)
  • Table 10: Angio Suites Market in Europe (2021-2030)
  • Table 11: Angio Suites Market in France (2021-2030)
  • Table 12: Angio Suites Market in Germany (2021-2030)
  • Table 13: Angio Suites Market in United Kingdom (2021-2030)
  • Table 14: Angio Suites Market in Italy (2021-2030)
  • Table 15: Angio Suites Market in Spain (2021-2030)
  • Table 16: Angio Suites Market in the Rest of Europe (2021-2030)
  • Table 17: Angio Suites Market in Asia-Pacific (2021-2030)
  • Table 18: Angio Suites Market in China (2021-2030)
  • Table 19: Angio Suites Market in Japan (2021-2030)
  • Table 20: Angio Suites Market in India (2021-2030)
  • Table 21: Angio Suites Market in Australia (2021-2030)
  • Table 22: Angio Suites Market in South Korea (2021-2030)
  • Table 23: Angio Suites Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Angio Suites Market in the Rest of the World (2021-2030)
  • Table 25: Angio Suites Market in the Middle East (2021-2030)
  • Table 26: Angio Suites Market in Africa (2021-2030)
  • Table 27: Angio Suites Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Angio Suites Market in Global (2021-2030)
  • Figure 3: Angio Suites Market in Global by Type (2021-2030)
  • Figure 4: Angio Suites Market in Global by Application (2021-2030)
  • Figure 5: Angio Suites Market in Global by Geography (2021-2030)
  • Figure 6: Angio Suites Market in North America (2021-2030)
  • Figure 7: Angio Suites Market in the United States (2021-2030)
  • Figure 8: Angio Suites Market in Canada (2021-2030)
  • Figure 9: Angio Suites Market in Mexico (2021-2030)
  • Figure 10: Angio Suites Market in Europe (2021-2030)
  • Figure 11: Angio Suites Market in France (2021-2030)
  • Figure 12: Angio Suites Market in Germany (2021-2030)
  • Figure 13: Angio Suites Market in United Kingdom (2021-2030)
  • Figure 14: Angio Suites Market in Italy (2021-2030)
  • Figure 15: Angio Suites Market in Spain (2021-2030)
  • Figure 16: Angio Suites Market in the Rest of Europe (2021-2030)
  • Figure 17: Angio Suites Market in Asia-Pacific (2021-2030)
  • Figure 18: Angio Suites Market in China (2021-2030)
  • Figure 19: Angio Suites Market in Japan (2021-2030)
  • Figure 20: Angio Suites Market in India (2021-2030)
  • Figure 21: Angio Suites Market in Australia (2021-2030)
  • Figure 22: Angio Suites Market in South Korea (2021-2030)
  • Figure 23: Angio Suites Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Angio Suites Market in the Rest of the World (2021-2030)
  • Figure 25: Angio Suites Market in the Middle East (2021-2030)
  • Figure 26: Angio Suites Market in Africa (2021-2030)
  • Figure 27: Angio Suites Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0329

Angio Suites Market by Type (Single-Plane and Bi-Plane), Application (Angiography, Angioplasty, Stenting, Bypass Surgery, and Others), and Geography (North-America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities worldwide

The angio suites market was valued at USD 2.18 billion in 2023, growing at a CAGR of 5.75% during the forecast period from 2024 to 2030 to reach USD 3.05 billion by 2030. The angio suites market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, peripheral artery disease (PAD), and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the angio suites market during the forecast period from 2024 to 2030.

Angio Suites Market Dynamics:

As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to recent data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are living with CAD around the world.

As per data by the American Heart Association (2023), around 200 million live with PAD globally on average. Also, as per the Global Burden of Disease (2019), there were 56.4 million prevalent cases of PAD among those aged 40 to 70, worldwide in 2019.

Angio suites are vital for diagnosing and treating cardiovascular diseases like CAD, PAD, and atrial fibrillation. Moreover, angio suites can be used for catheter-based procedures like atrial fibrillation ablation to restore normal heart rhythm.

Another prominent factor responsible for the growth of the angio suites market is the constant technological developments taking place in the angio suites market for product design, and for increasing its safety and precision. For instance, in October 2021, Yashoda Hospitals, located in Secunderabad, India launched a 'Bi-Plane Neuro Angio Procedure Suite' with DTAS (Direct to Angio Suite) technology used for providing quick and highly advanced treatment in cases of brain stroke and neurological emergencies such as heart attacks.

Increased product developmental activities by regulatory bodies worldwide is also slated to witness market growth for angio suites. For example in May 2022, Philips announced FDA 510(k) clearance for its new MR 7700 3.0T MR system, giving high performance and precision for both research and advanced clinical diagnostics.

Therefore, all the factors stated above collectively will drive the overall angio suites market growth.

However, side effects such as infections, hematoma, vessel injuries, lack of skilled workforce and medical infrastructure, and others may prove to be challenging factors for the angio suites market growth.

Angio Suites Market Segment Analysis:

Angio Suites Market by Type (Single-Plane and Bi-Plane), Application (Angiography, Angioplasty, Stenting, Bypass Surgery, and Others), and Geography (North-America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of angio suites market, the stenting category is expected to have a significant revenue share in the year 2023. This can be ascribed to an increase in stenting procedures around the world, required in acute cases of stroke, rising prevalence of stroke cases globally, leading to serious consequences like disability and death, this segment of the angio suites market is expected to generate considerable revenue.

Furthermore, technological advancements and product innovations taking place in the development of wearable angio suites are likely to propel the angio suites market growth. For instance, in June 2022, Siemens Healthineers, launched the Angiography System Artis Icono, for various applications like stenting, stroke diagnosis and treatment and others. It is enabled with new system mechanics and image chains for 2D and 3D imaging with seamless integration and a third-party interface.

Angio suites designed for stenting procedures feature advanced imaging technologies, specialized catheterization tools, and patient monitoring systems. They are primarily used to treat CAD and PAD by placing stents to keep narrowed or blocked arteries open, thus improving blood flow and reducing the risk of heart attacks. These suites also facilitate emergency interventions for acute coronary syndromes, ensuring timely cardiovascular care.

Therefore, the widespread uses and various key features offered by stenting category, that enhance performance and usability are solidifying the impact on the growth of the overall angio suites market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall angio suites market:

Among all the regions, North America is expected to dominate the angio suites market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high prevalence of CAD and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the angio suites market in the North America region during the forecast period from 2024 to 2030.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure among others.

Data from the Canadian Institute for Health Information (2024), stated that in 2022, 2.4 million Canadians were affected by heart disease. Also, according to the American Health Association (2022), Canada stands the second most to be affected by stroke globally in the year 2021.

Angio suites enable crucial diagnostic procedures like angiography to visualize coronary arteries and identify blockages. For myocardial infarction, angio suites facilitate interventions such as angioplasty and stenting to restore blood flow to the heart. Their versatility also allows for the treatment of various heart conditions, ensuring timely diagnosis and effective care.

Rising product developmental activities by regulatory bodies in the region will further boost the market for angio suites. For example, in March 2022, Philips received 510(k) market clearance from the U.S. Food & Drug Administration (FDA) for its angio suite Philips Capsule Surveillance solution, paving the way for widespread deployment across healthcare systems in the US. The angio suite is capable of utilizing streaming data from virtually any connected medical device and helps in the analysis to generate actionable insights and alerts.

Additionally, in June 2022, Canon Medical Systems decided to collaborate with The Harley Street Healthcare Group Canada to launch a group of innovative diagnostic centers across Ontario. The diagnostic center is said to possess a highly equipped Angiography suite with the latest X-ray generators, Molecular Imaging, Ultrasound, and Healthcare Informatics.

Therefore, the presence of a large patient population base with heart disorders, coupled with a rise in regulatory approvals for angio suites is expected to bolster the growth of the angio suites market in the North American region during the forecast period.

Angio Suites Market key players:

Some of the key market players operating in the angio suites market include Siemens Healthineers, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc., 3D Systems, Inc., GE HealthCare, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical International Limited, ZEISS International, Guerbet, Surgical Science, B.Braun Melsungen AG, and others.

Recent Developmental Activities in the Angio Suites Market:

  • In June 2022, Siemens Healthineers, launched the Angiography System Artis Icono, for precise tumor embolization. It is enabled with new system mechanics and image chains for 2D and 3D imaging with seamless integration and a third-party interface.
  • In December 2021, GE Healthcare, an auxiliary company of well-known Massachusetts, United States-based company "General Electric" announced the successful acquisition of Boston, United States-based imaging company "BK Medical".

Key Takeaways from the Angio Suites Market Report Study

  • Market size analysis for current angio suites market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the angio suites market.
  • Various opportunities available for the other competitors in the angio suites market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current angio suites market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for automated external defibrillator market growth in the coming future?

Target Audience who can be benefited from this Angio Suites Market Report Study

  • Angio suites product providers
  • Research organizations and consulting companies
  • Angio suites-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in angio suites
  • Various end-users who want to know more about the angio suites market and the latest technological developments in the angio suites market.

Frequently Asked Questions for the Angio Suites Market:

1. What are angio suites?

  • The angio suite is an examination room where complex surgical procedures like angiography, stenting, bypass surgery, etc. are performed with high precision. It helps in the detection and observation of damaged blood vessels present in different organs, helping in the diagnosis and treatment of conditions like aneurysms, vascular stenosis, coronary atherosclerosis, etc.

2. What is the market for angio suites?

  • The angio suites market was valued at USD 2.18 billion in 2023, growing at a CAGR of 5.75% during the forecast period from 2024 to 2030 to reach USD 3.05 billion by 2030.

3. What are the drivers for the angio suites market?

  • The angio suites market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation, peripheral artery disease (PAD), and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the angio suites market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the angio suites market?

  • Some of the key market players operating in the angio suites market include Siemens Healthineers, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi, Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc., 3D Systems, Inc., GE HealthCare, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical International Limited, ZEISS International, Guerbet, Surgical Science, B.Braun Melsungen AG, and others.

5. Which region has the highest share in the angio suites market?

North America is expected to dominate the overall angio suites market during the forecast period from 2024 to 2030. This can be attributed to several factors including the high prevalence of coronary artery disease and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the angio suites market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Angio Suites Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Angio Suites Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Angio Suites Market Key Factors Analysis

  • 5.1. Angio Suites Market Drivers
    • 5.1.1. Increasing cases of chronic disorders
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Rising geriatric population
  • 5.2. Angio Suites Market Restraints and Challenges
    • 5.2.1. Side effects such as infections, hematoma, and vessel injuries
    • 5.2.2. Lack of skilled workforce and medical infrastructure
  • 5.3. Angio Suites Market Opportunities
    • 5.3.1. Integration of AI, robotics and automation
    • 5.3.2. Increasing regulatory and research opportunities

6. Angio Suites Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Angio Suites Market Assessment

  • 7.1. By Type
    • 7.1.1. Single-plane
    • 7.1.2. Bi-plane
  • 7.2. By Application
    • 7.2.1. Angiography
    • 7.2.2. Angioplasty
    • 7.2.3. Stenting
    • 7.2.4. Bypass Surgery
    • 7.2.5. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Angio Suites Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Angio Suites Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Angio Suites Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Angio Suites Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Angio Suites Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.3. India Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Angio Suites Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Angio Suites Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Angio Suites Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Angio Suites Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Angio Suites Market Size in USD million (2021-2030)

8. Angio Suites Market Company and Product Profiles

  • 8.1. Siemens Healthineers
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Koninklijke Philips N.V
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Lam Vascular and Associates
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Hitachi, Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. ESAOTE SPA
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. IMRIS
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Onex Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Canon Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. 3D Systems, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. GE HealthCare
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Shimadzu Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. GIMIAS
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. FUJIFILM Holdings Corporation
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Hologic, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Planmeca
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Mindray Medical International Limited
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. ZEISS International
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Guerbet
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Surgical Science
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. B.Braun Melsungen AG
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us